Abstract

Agonist-induced conformational changes in the ligand-binding domains (LBD) of glutamate receptor ion channels provide the driving force for molecular rearrangements that mediate channel opening and subsequent desensitization. The resulting regulated transmembrane ion fluxes form the basis for most excitatory neuronal signaling in the brain. Crystallographic analysis of the GluR2 LBD core has revealed a ligand-binding cleft located between two lobes. Channel antagonists stabilize an open cleft, whereas agonists stabilize a closed cleft. The crystal structure of the apo form is similar to the antagonist-bound, open state. To understand the conformational behavior of the LBD in the absence of crystal lattice constraints, and thus better to appreciate the thermodynamic constraints on ligand binding, we have undertaken a solution x-ray scattering study using two different constructs encoding either the core or an extended LBD. In agreement with the GluR2 crystal structures, the LBD is more compact in the presence of agonist than it is in the presence of antagonist. However, the time-averaged conformation of the ligand-free core in solution is intermediate between the open, antagonist-bound state and the closed, agonist-bound state, suggesting a conformational equilibrium. Addition of peptide moieties that connect the core domain to the other functional domains in each channel subunit appears to constrain the conformational equilibrium in favor of the open state.

Highlights

  • §§ Present address: Institut de Biochimie et de Biophysique Moleculaire et Cellulaire, CNRS UMR 8619 Universitede Paris-Sud, Batiment 430, 91405 Orsay Cedex, France

  • Three iGluR ligand-binding domain (LBD) constructs were used in this work

  • The S1S2J construct corresponds to the refolded, bacterially expressed periplasmic binding proteins (PBP)-homologous core of the GluR2flop subunit used in most crystallographic studies [11, 33]

Read more

Summary

EXPERIMENTAL PROCEDURES

Protein Expression and Purification—The core GluR2 LBD (“S1S2J”) that had been used in crystallographic studies of the domain was expressed bacterially, purified, and refolded as described [11, 23]. For the S1S2-D construct, affinity and ion-exchange purifications in the absence of glutamate were followed by serial dialysis against glutamate-free SAXS buffers (overall volumetric dilution Նϳ1.5 ϫ 107-fold). This protocol has been used in previous spectroscopic studies that would have been sensitive to the presence of significant levels of bound agonist: none was detected [9, 25, 26]. For the S1S2J and S1S2L constructs, 1 mM glutamate was present in the samples following ion-exchange purification, but was removed by serial dialysis against glutamate-free SAXS buffers (overall volumetric dilution Ն1013-fold). All fits were obtained with values of ⌬␳b ϭ ␳b Ϫ ␳0 in the range (0.03– 0.04 eϪ/Å3) corresponding to a density of about 1.10 times that of the bulk solvent and commonly observed with soluble proteins

RESULTS AND DISCUSSION
65 Ϯ 3 62 Ϯ 3 59 Ϯ 2
CONCLUSIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.